Reach MHRA_GPVP readiness without rebuilding your policy programme
MHRA Good Pharmacovigilance Practice (GPvP) governs the system Marketing Authorisation Holders use in the UK to monitor + report on the safety of medicinal products. Largely aligned with EU GVP modules — pharmacovigilance system master file (PSMF), QPPV (Qualified Person for Pharmacovigilance), ICSR reporting, PSURs / PBRERs, risk management plans, signal management + post-authorisation safety studies. MHRA inspectorate conducts routine + for-cause GPvP inspections with critical / major / minor finding grading. Failure has resulted in regulatory action + market withdrawals. Quick Policy maps MHRA_GPVP into the policy families, controls, and evidence your team needs — and keeps it current between audits.
MHRA_GPVP
Framework
UK
Jurisdiction
Supervisory
Assurance
365 days
Review cadence
MHRA_GPVP quick answer
Standard facts
Framework: MHRA_GPVP
Authority: UK Medicines and Healthcare products Regulatory Agency (MHRA)
Jurisdiction: UK
Why MHRA_GPVP matters for your operating model
MHRA_GPVP doesn't just dictate document templates — it shapes which controls auditors test, what evidence they ask for, and which gaps surface first during diligence. Getting it wrong creates renewal slippage, audit findings, and stalled customer deals.
- • Issued by UK Medicines and Healthcare products Regulatory Agency (MHRA) and primarily enforced in UK.
- • Directly shapes policy families including Pharmacovigilance, Regulatory Affairs — these are the artefacts assessors open first.
- • Common artifacts include Policy.
- • Obligation model: Mandatory In Scope — meaning you need defensible reasoning for in-scope vs out-of-scope decisions, not just signed policies.
How Quick Policy helps you stand up MHRA_GPVP
The platform turns MHRA_GPVP from a PDF of requirements into a live operating model — policies, training, evidence, and audit-export packs that update in lock-step when the standard or your business changes.
- • Adopt MHRA_GPVP once and Quick Policy seeds the right policy families (Pharmacovigilance, Regulatory Affairs) with applicability rationale your auditor can follow.
- • Common artifacts include Policy.
- • Review cadence is enforced at ~365 days so policies don't silently expire ahead of recertification.
- • Standard updates (MHRA_GPVP revisions, errata, regulator guidance) trigger an applicability re-check across your active policies — not a full rewrite.
Policy families commonly involved
Recommended artifacts and context
Industry tags: LIFE_SCIENCES
Obligation model: Mandatory In Scope
Coverage depth: Profile
How Quick Policy operationalizes MHRA_GPVP
Turn standards context into drafting, review, training, and evidence workflows that are easier to maintain over time.
Capture Core Profile
Admins complete adaptive onboarding to establish operating model, risk posture, and compliance objectives.
Determine Applicable Standards
Standards applicability ranks obligations by industry, geography, services, and data profile.
Generate and Harmonise Policy
Three-pass generation drafts, repairs contradictions, and validates coverage before reviewer handoff.
Review and Approve
Approvers validate policy language, mappings, and obligations using structured workflow stages.
Need adjacent guidance?
Use these pages for broader platform, industry, or buying context around MHRA_GPVP.